ROCKVILLE, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL FOUNDATION FOR CANCER RESEARCH, founded in 1973, is a community nonprofit in the Medical Research sector that reported $9.2M in total revenue in fiscal year 2023. Revenue grew 9% year-over-year, indicating healthy expansion.
The National Foundation for Cancer Research (NFCR) is a leading public charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer. NFCR has distinguished itself in the cancer research sector by emphasizing long-term, transformative research often overlooked by other major funding sources. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. Since 1973, NFCR has provided more than $415 million in support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment. NFCR is committed to fighting cancer by funding high-risk, high-impact, and potentially high-reward discoveries in the labs and transforming them into life-saving treatments for cancer patients. Through global collaboration, NFCR is making unique impacts on new, accelerated paths to a cure. NFCR envisions a world without cancer!
CANCER RESEARCH - SEE SCHEDULE O
CANCER PREVENTION EDUCATION TO THE PUBLIC - SEE SCHEDULE O
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $9,162,442 | $8,408,059 | +0.1% |
| Expenses | $9,790,531 | $8,484,908 | +0.2% |
| Net Income | $-628,089 | $-76,849 | +7.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SUJUAN BA | PRESIDENT/CEO | 40.0 |
Officer
|
$471,385 | $81,925 | $553,310 |
| KWOK LEUNG | CFO/SECRETARY | 40.0 |
Officer
|
$204,079 | $30,434 | $234,513 |
| BRIAN WACHTEL | EXECUTIVE DIRECTOR | 40.0 |
Highest
|
$151,108 | $17,381 | $168,489 |
| ZETING WANG | SR. DIR OF DIRECT RESPONSE | 40.0 |
Highest
|
$124,087 | $11,940 | $136,027 |
| ALFRED SLANETZ | CHAIR OF THE BOARD | 5.0 |
Officer
Director
|
$0 | $0 | $0 |
| BRIAN LEYLAND-JONES | TREASURER | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| JUDITH P BARNHARD | DIRECTOR | 1.5 |
Director
|
$0 | $0 | $0 |
| KAREN BURKE | DIRECTOR | 1.5 |
Director
|
$0 | $0 | $0 |
| LANCE KAWAGUCHI | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| Edward s west | Director (THRU 04/26/2023) | 1.0 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $9,162,442 | $9,790,531 | $10,533,674 | $-628,089 |
| 2022 | $8,408,059 | $8,484,908 | $10,719,078 | $-76,849 |
| 2021 | $10,081,253 | $10,194,507 | $12,143,234 | $-113,254 |
| 2020 | $11,465,290 | $10,830,001 | $12,283,856 | $635,289 |
| 2019 | $10,937,905 | $14,532,374 | $10,554,744 | $-3,594,469 |
| 2018 | $13,696,895 | $15,147,731 | $13,294,160 | $-1,450,836 |
Compare NATIONAL FOUNDATION FOR CANCER RESEARCH with other nonprofits in Maryland and across the country.